LONDON, Aug 3 (Reuters) - AstraZeneca (AZN.L), opens new tab investors punished the pharmaceutical firm on Monday over reports of merger talks with U.S. rival Bristol Myers Squibb (BMY.N), opens new ...
Since early May 2026, Microsoft Threat Intelligence has observed Storm-2945, a sub-cluster of Midnight Blizzard, conducting widespread but targeted traffic manipulation attacks involving hospitality ...
On Monday, Oppenheimer analyst Param Singh reiterated his "outperform" rating and $200 price target on Palantir. Revenue could grow 85% year over year, says Singh, beating consensus forecasts for 80% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results